UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Early prophylaxis in children with severe haemophilia A: clinical and ultrasound imaging outcomes

Haemophilia : the official journal of the World Federation of Hemophilia, 2016-03, Vol.22 (2), p.218-224

2016

Volltextzugriff (PDF)

Prophylaxis in congenital factor VII deficiency: indications, efficacy and safety. Results from the Seven Treatment Evaluation Registry (STER)

Haematologica (Roma), 2013-04, Vol.98 (4), p.538-544

2013

Volltextzugriff (PDF)

Diagnostic challenges in von Willebrand disease. Report of two cases with emphasis on multimeric and molecular analysis

Platelets (Edinburgh), 2021-07, Vol.32 (5), p.1-700

2021

Volltextzugriff (PDF)

Diagnostic delay in acquired haemophilia: Analysis of causes and consequences in a 20‐year Spanish cohort

Haemophilia : the official journal of the World Federation of Hemophilia, 2018-05, Vol.24 (3), p.e163-e166

2018

Volltextzugriff (PDF)

Replacement therapy for invasive procedures in patients with haemophilia: literature review, European survey and recommendations

Haemophilia : the official journal of the World Federation of Hemophilia, 2009-05, Vol.15 (3), p.639-658

2009

Volltextzugriff (PDF)

Adherence to prophylaxis and quality of life in children and adolescents with severe haemophilia A

Haemophilia : the official journal of the World Federation of Hemophilia, 2015-07, Vol.21 (4), p.458-464

2015

Volltextzugriff (PDF)

Non-genetic risk factors and the development of inhibitors in haemophilia: a comprehensive review and consensus report

Haemophilia : the official journal of the World Federation of Hemophilia, 2010-09, Vol.16 (5), p.747-766

2010

Volltextzugriff (PDF)

Immunogenicity, efficacy and safety of Nuwiq® (human‐cl rhFVIII) in previously untreated patients with severe haemophilia A—Interim results from the NuProtect Study

Haemophilia : the official journal of the World Federation of Hemophilia, 2018-03, Vol.24 (2), p.211-220

2018

Volltextzugriff (PDF)

Moderate and severe haemophilia in Spain: An epidemiological update

Haemophilia : the official journal of the World Federation of Hemophilia, 2018-05, Vol.24 (3), p.e136-e139

2018

Volltextzugriff (PDF)

Immune tolerance induction in patients with haemophilia a and inhibitors: effectiveness and cost analysis in an European Cohort (The ITER Study)

Haemophilia : the official journal of the World Federation of Hemophilia, 2016-01, Vol.22 (1), p.96-102

2016

Volltextzugriff (PDF)

Sodium content in products used to treat haemophilia

Haemophilia : the official journal of the World Federation of Hemophilia, 2016-07, Vol.22 (4), p.e324-e327

2016

Volltextzugriff (PDF)

International cross-cultural validation study of the Canadian Haemophilia Outcomes: Kids' Life Assessment Tool

Haemophilia : the official journal of the World Federation of Hemophilia, 2015-05, Vol.21 (3), p.351-357

2015

Volltextzugriff (PDF)

Practical aspects of DDAVP use in patients with von Willebrand Disease undergoing invasive procedures: a European survey

Haemophilia : the official journal of the World Federation of Hemophilia, 2016-01, Vol.22 (1), p.110-120

2016

Volltextzugriff (PDF)

Practical aspects of factor concentrate use in patients with von Willebrand disease undergoing invasive procedures: a European survey

Haemophilia : the official journal of the World Federation of Hemophilia, 2016-09, Vol.22 (5), p.739-751

2016

Volltextzugriff (PDF)

Advanced cell‐based modeling of the royal disease: characterization of the mutated F9 mRNA

Journal of thrombosis and haemostasis, 2017-11, Vol.15 (11), p.2188-2197

2017

Volltextzugriff (PDF)

Continuous infusion in haemophilia: current practice in Europe

Haemophilia : the official journal of the World Federation of Hemophilia, 2012-09, Vol.18 (5), p.753-759

2012

Volltextzugriff (PDF)

Advanced cell‐based modeling of the royal disease: characterization of the mutated F9mRNA

Journal of thrombosis and haemostasis, 2017-11, Vol.15 (11), p.2188-2197

2017

Volltextzugriff (PDF)

Cross-cultural development and psychometric evaluation of a patient-reported health-related quality of life questionnaire for adults with haemophilia

Haemophilia : the official journal of the World Federation of Hemophilia, 2008-09, Vol.14 (5), p.1023-1034

2008

Volltextzugriff (PDF)

The study of the effect of splicing mutations in von Willebrand factor using RNA isolated from patients’ platelets and leukocytes

Journal of thrombosis and haemostasis, 2011-04, Vol.9 (4), p.679-688

2011

Volltextzugriff (PDF)

Prophylactic treatment of haemophilia patients with inhibitors: clinical experience with recombinant factor VIIa in European Haemophilia Centres

Haemophilia : the official journal of the World Federation of Hemophilia, 2007-09, Vol.13 (5), p.502-507

2007

Volltextzugriff (PDF)

Proteomic analysis of platelet N -glycoproteins in PMM2-CDG patients

Thrombosis research, 2014-03, Vol.133 (3), p.412-417

2014

Volltextzugriff (PDF)

Acquired haemophilia A. First line treatment with calcineurin inhibitors and steroid pulses: a 10-year follow-up study

Haemophilia : the official journal of the World Federation of Hemophilia, 2012-09, Vol.18 (5), p.789-793

2012

Volltextzugriff (PDF)

Should prophylaxis be used in adolescent and adult patients with severe haemophilia? An European survey of practice and outcome data

Haemophilia : the official journal of the World Federation of Hemophilia, 2007-09, Vol.13 (5), p.473-479

2007

Volltextzugriff (PDF)

The ‘royal disease’ mutation in a Spanish patient

Journal of thrombosis and haemostasis, 2010-10, Vol.8 (10), p.2316-2317

2010

Volltextzugriff (PDF)

The optimal mode of delivery for the haemophilia carrier expecting an affected infant: further considerations

Haemophilia : the official journal of the World Federation of Hemophilia, 2011-09, Vol.17 (5), p.818-819

2011

Volltextzugriff (PDF)

1 – 25 von 164

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(148)
Mit Volltextzugriff
(121)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(115)
Life Sciences & Biomedicine
(113)
Humans
(95)
Hematology
(68)
Male
(59)
Female
(42)
Adult
(40)
Biological And Medical Sciences
(35)
Adolescent
(32)
Middle Aged
(30)
Child
(29)
Hemophilia A - Drug Therapy
(21)
Medical Sciences
(21)
Child, Preschool
(19)
Haemophilia
(19)
Cardiovascular System & Cardiology
(18)
Fundamental And Applied Biological Sciences. Psychology
(17)
Agriculture
(16)
Aged
(15)
Cohort Studies
(15)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Early prophylaxis in children with severe haemophilia A: clinical and ultrasound imaging outcomes

Prophylaxis in congenital factor VII deficiency: indications, efficacy and safety. Results from the Seven Treatment Evaluation Registry (STER)

Diagnostic challenges in von Willebrand disease. Report of two cases with emphasis on multimeric and molecular analysis

Diagnostic delay in acquired haemophilia: Analysis of causes and consequences in a 20‐year Spanish cohort

Replacement therapy for invasive procedures in patients with haemophilia: literature review, European survey and recommendations

Adherence to prophylaxis and quality of life in children and adolescents with severe haemophilia A

Non-genetic risk factors and the development of inhibitors in haemophilia: a comprehensive review and consensus report

Immunogenicity, efficacy and safety of Nuwiq® (human‐cl rhFVIII) in previously untreated patients with severe haemophilia A—Interim results from the NuProtect Study

Moderate and severe haemophilia in Spain: An epidemiological update

Immune tolerance induction in patients with haemophilia a and inhibitors: effectiveness and cost analysis in an European Cohort (The ITER Study)

Sodium content in products used to treat haemophilia

International cross-cultural validation study of the Canadian Haemophilia Outcomes: Kids' Life Assessment Tool

Practical aspects of DDAVP use in patients with von Willebrand Disease undergoing invasive procedures: a European survey

Practical aspects of factor concentrate use in patients with von Willebrand disease undergoing invasive procedures: a European survey

Advanced cell‐based modeling of the royal disease: characterization of the mutated F9 mRNA

Continuous infusion in haemophilia: current practice in Europe

Advanced cell‐based modeling of the royal disease: characterization of the mutated F9mRNA

Cross-cultural development and psychometric evaluation of a patient-reported health-related quality of life questionnaire for adults with haemophilia

The study of the effect of splicing mutations in von Willebrand factor using RNA isolated from patients’ platelets and leukocytes

Prophylactic treatment of haemophilia patients with inhibitors: clinical experience with recombinant factor VIIa in European Haemophilia Centres

Proteomic analysis of platelet N -glycoproteins in PMM2-CDG patients

Acquired haemophilia A. First line treatment with calcineurin inhibitors and steroid pulses: a 10-year follow-up study

Should prophylaxis be used in adolescent and adult patients with severe haemophilia? An European survey of practice and outcome data

The ‘royal disease’ mutation in a Spanish patient

The optimal mode of delivery for the haemophilia carrier expecting an affected infant: further considerations

Suchergebnisse filtern